Somewhat Critical Media Coverage Somewhat Unlikely to Impact Maximus (MMS) Share Price

Media coverage about Maximus (NYSE:MMS) has been trending somewhat negative recently, according to Accern. The research group identifies positive and negative news coverage by analyzing more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Maximus earned a news sentiment score of -0.03 on Accern’s scale. Accern also gave news articles about the health services provider an impact score of 46.0291466930488 out of 100, meaning that recent news coverage is somewhat unlikely to have an impact on the company’s share price in the next several days.

Here are some of the media stories that may have effected Accern’s analysis:

Shares of Maximus (NYSE MMS) traded up $0.90 during trading hours on Monday, reaching $66.37. The company’s stock had a trading volume of 253,607 shares, compared to its average volume of 361,430. Maximus has a one year low of $51.74 and a one year high of $66.96. The firm has a market capitalization of $4,243.90, a P/E ratio of 21.05, a PEG ratio of 2.46 and a beta of 1.32.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, November 30th. Stockholders of record on Wednesday, November 15th will be paid a dividend of $0.045 per share. This represents a $0.18 annualized dividend and a dividend yield of 0.27%. The ex-dividend date is Tuesday, November 14th. Maximus’s payout ratio is 5.66%.

MMS has been the topic of a number of recent research reports. Robert W. Baird initiated coverage on Maximus in a research report on Sunday, September 3rd. They issued a “neutral” rating on the stock. Zacks Investment Research downgraded Maximus from a “buy” rating to a “hold” rating in a report on Tuesday, October 10th. BidaskClub downgraded Maximus from a “hold” rating to a “sell” rating in a report on Monday, July 24th. Canaccord Genuity decreased their price target on Maximus from $62.00 to $61.00 and set a “hold” rating for the company in a report on Friday, November 10th. Finally, Maxim Group set a $66.00 price target on Maximus and gave the company a “hold” rating in a report on Thursday, August 3rd. Two analysts have rated the stock with a sell rating and six have given a hold rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus target price of $64.33.

ILLEGAL ACTIVITY NOTICE: “Somewhat Critical Media Coverage Somewhat Unlikely to Impact Maximus (MMS) Share Price” was originally reported by TrueBlueTribune and is owned by of TrueBlueTribune. If you are accessing this article on another site, it was stolen and republished in violation of US and international trademark & copyright laws. The original version of this article can be read at

In other news, President Bruce Caswell sold 8,000 shares of the company’s stock in a transaction that occurred on Tuesday, September 5th. The stock was sold at an average price of $60.23, for a total transaction of $481,840.00. Following the completion of the transaction, the president now directly owns 35,904 shares of the company’s stock, valued at approximately $2,162,497.92. The sale was disclosed in a filing with the SEC, which is available at this link. Also, General Counsel David Francis sold 1,373 shares of the company’s stock in a transaction that occurred on Friday, November 17th. The stock was sold at an average price of $65.35, for a total value of $89,725.55. Following the transaction, the general counsel now directly owns 13,617 shares of the company’s stock, valued at $889,870.95. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 75,773 shares of company stock valued at $4,814,579. Corporate insiders own 3.10% of the company’s stock.

About Maximus

MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.

Insider Buying and Selling by Quarter for Maximus (NYSE:MMS)

Receive News & Ratings for Maximus Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Maximus Inc. and related companies with's FREE daily email newsletter.

Latest News

Leave a Reply